You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

odronextamab

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma (MZL) Trial in Chiang Mai (Odronextamab, Lenalidomide,

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma (MZL)
  • Odronextamab
  • +2 more
  • Chiang Mai, Thailand
    Chiang Mai University
Nov 20, 2023

Follicular Lymphoma (FL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Odronextamab
  • +6 more
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Follicular Lymphoma (FL) Trial in Noblesville (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Follicular Lymphoma (FL)
  • Odronextamab
  • +5 more
  • Noblesville, Indiana
    Investigative Clinical Research of Indiana
Oct 18, 2023

Diffuse Large B-cell Lymphoma (DLBCL) Trial in Westbury (Odronextamab, Rituximab, Cyclophosphamide)

Recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Odronextamab
  • +5 more
  • Westbury, New York
    Clinical Research Alliance Inc
Oct 13, 2023

Relapsed or Refractory (R/R) Follicular Lymphoma (FL), DLBCL (DLBCL) Trial (Odronextamab)

Available
  • Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • Odronextamab
  • (no location specified)
Nov 8, 2022

B-cell Non-Hodgkins Lymphoma (B-NHL) Trial (Odronextamab, REGN5837)

Not yet recruiting
  • B-cell Non-Hodgkins Lymphoma (B-NHL)
  • (no location specified)
Jan 5, 2023

B-cell Non Hodgkin Lymphoma Trial (Odronextamab, Loncastuximab tesirine, Rituximab)

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Odronextamab
  • +8 more
  • (no location specified)
Aug 7, 2023

B-cell Non-Hodgkin Lymphoma (NHL) Trial in Worldwide (Odronextamab)

Recruiting
  • B-cell Non-Hodgkin Lymphoma (NHL)
  • Odronextamab
  • Chicago, Illinois
  • +122 more
Apr 1, 2022